1-3 of 3
Marta Rozanski
Close
Sort by
Journal Articles

Treatment with Bendamustine, Thalidomide and Prednisolone (BPT) in Patients with Refractory or Relapsed Multiple Myeloma after Autologous Stem Cell Transplantation or Conventional Chemotherapy: Results of a Phase I Clinical Trial.

Wolfram Poenisch, MD, Marta Rozanski, Hartmut Goldschmidt, MD, Franz-Albert Hoffmann, MD, Thomas Boldt, MD, Andreas Schwarzer, MD, Ute Ruffert, MD, Robert Rohrberg, MD, Elke Schwalbe, MD, Jens Uhlig, MD, Thomas Zehrfeld, MD, Veronika Schirmer, MD, Antje Haas, MD, Ute Kreibich, MD, Dietger Niederwieser, MD
Journal: Blood
Blood (2006) 108 (11): 3564.
https://doi.org/10.1182/blood.V108.11.3564.3564
Published: 2006
Journal Articles

Bendamustine in Combination with Thalidomide and Prednisolone (BPT) in Patients with Refractory or Relapsed Multiple Myeloma after Conventional Chemotherapy: Final Results of a Phase I Study.

Wolfram Poenisch, MD, Marta Rozanski, Sabine Leiblein, PhD, Hartmut Goldschmidt, MD, Franz A. Hoffmann, MD, Thomas Boldt, MD, Robert Rohrberg, MD, Elke Schwalbe, MD, Jens Uhlig, MD, Dietger Niederwieser, MD
Journal: Blood
Blood (2005) 106 (11): 5154.
https://doi.org/10.1182/blood.V106.11.5154.5154
Published: 2005
Journal Articles

Bendamustine in Combination with Thalidomide and Prednisolone (BPT) in Patients with Refractory or Relapsed Multiple Myeloma (MM): Preliminary Results of a Phase I Clinical Trial.

Wolfram Poenisch, MD, Marta Rozanski, Sabine Leiblein, PhD, Hartmut Goldschmidt, MD, Almut Wegner, PhD, Dietger Niederwieser, MD
Journal: Blood
Blood (2004) 104 (11): 4901.
https://doi.org/10.1182/blood.V104.11.4901.4901
Published: 2004